- Previous Close
37,650.00 - Open
38,000.00 - Bid 37,600.00 x --
- Ask 37,950.00 x --
- Day's Range
37,650.00 - 38,000.00 - 52 Week Range
25,250.00 - 47,000.00 - Volume
158 - Avg. Volume
4,981 - Market Cap (intraday)
483.712B - Beta (5Y Monthly) 0.82
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 25, 2025 - Mar 3, 2025
- Forward Dividend & Yield 105.00 (0.26%)
- Ex-Dividend Date Dec 27, 2023
- 1y Target Est
--
Namyang Dairy Products Co., Ltd manufactures and sells dairy products in South Korea and internationally. It offers babies products under Imperial Dream XO, Imperial Kid XO, Imperial Mom XO, I am Mother, Star Grow, Blood Crown, Koko Crown Picky Eater, Namyang KI PLUS PREMIUM, Namyang Shanyang Rufen, Hope Allegy, and Hope Doctor brand names. It also provides coffee beverages and mixes, yogurt, beverages, cheese, raw and soyabean milk, and whipping cream and creamer; and Namyang KETONIA, a liquid formula for high-fat ketogenic dietary food for infants and young children, as well as real estate services. The company was founded in 1964 and is headquartered in Seoul, South Korea. Namyang Dairy Products Co., Ltd operates as a subsidiary of Hahn & Co. No. 19 Co., Ltd.
company.namyangi.com1,891
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 003925.KS
View MorePerformance Overview: 003925.KS
Trailing total returns as of 12/12/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 003925.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 003925.KS
View MoreValuation Measures
Market Cap
483.71B
Enterprise Value
415.55B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.34
Price/Book (mrq)
0.49
Enterprise Value/Revenue
0.43
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.68%
Return on Assets (ttm)
-5.72%
Return on Equity (ttm)
-9.43%
Revenue (ttm)
974.28B
Net Income Avi to Common (ttm)
-45.51B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
79.52B
Total Debt/Equity (mrq)
2.31%
Levered Free Cash Flow (ttm)
31.31B